Friday, June 30, 2017

Facial Rejuvenation May Involve More ...

Facial Rejuvenation May Involve More Than Skin Tightening


Facial Rejuvenation May Involve More Than Skin Tightening | eReport | Plastic Surgery Practice

Most people worry about developing wrinkles and want to delay the effects of aging as much as possible to ensure they look their best. However, a new study published in the Journal of Experimental Social Psychology may prove there are more drawbacks to having wrinkles than just the aesthetics.

Wednesday, June 28, 2017

Botulinum Toxin Injections Between the Brows Produce Significant Patient Satisfaction Rates

Botulinum toxin type A injections are the most common cosmetic procedure performed in the United States. There were 4.3 million procedures performed in 2015 accounting for 42 percent of all cosmetic procedures in that year, based on the Cosmetic Surgery National Data Bank Statistics from the American Society for Aesthetic Plastic Surgery, (ASAPS). According to a 2016 study published in the Aesthetic Surgery Journal, the official publication of ASAPS, patient satisfaction with their overall facial appearance increased by 28 percent with injections to the so-called “11s” (the glabellar rhytids, which are the lines that appear between the brows as we age).
The satisfaction rate was determined based on participating patients’ completion of the FACE-Q survey, a newly developed and validated patient-reported outcome instrument that can be used for measuring a patient’s own perceptions of cosmetic facial procedures. The survey consists of 63 questions asking patients to evaluate their overall appearance, age appearance, and the appearance of cheeks, nasolabial folds, lower face and jawline, chin and neck.
Dr. Daniel C. Mills, president of ASAPS states, “The results of this study are not surprising and validate what we’ve suspected for quite some time. I see an ever-increasing influx of patients in my practice in Laguna Beach, California requesting botulinum toxin type A injections to the area between the brows and other areas on the face, like the crow’s feet and forehead as a preventative anti-aging or pre-aging measure from patients in their 20s up to their 70s. It’s a quick nonsurgical fix that packs a powerful punch. This new study reaffirms the efficacy of botulinum toxin type A and the satisfaction it brings to patients.”
The study’s authors examined 57 female patients who completed the FACE-Q survey. After the baseline survey, the patients received injections of one brand of botulinum toxin type A, (Botox, Dysport or Xeomin) in the region between the brows. Two weeks post-injection, the patients completed the FACE-Q survey again. The percentage changes in patient responses from the first to second surveys were assessed to determine how the injections affected patient satisfaction with their facial appearance.
Patients stated that they believe they look an average of 5.6 years younger post-injection with any of the botulinum toxin type A products. The average age of the 57 patients with pre- and post-neurotoxin FACE-Q responses was 49.6 years (range of 32-75 years old).
“This indicates that patients’ satisfaction with their overall facial appearance was statistically significantly greater after receiving the injections, and certainly accounts for the continued success of neurotoxin popularity to reduce the signs of aging,” states Dr. Ivona Percec, the study’s senior author.
To view the complete study, visit the Aesthetic Surgery Journal website, academic.oup.com/asj.
About ASAPS
The American Society for Aesthetic Plastic Surgery (ASAPS), is recognized as the world’s leading organization devoted entirely to aesthetic plastic surgery and cosmetic medicine of the face and body. ASAPS is comprised of more than 2,600 plastic surgeons; active members are certified by the American Board of Plastic Surgery (USA) or by the Royal College of Physicians and Surgeons of Canada and have extensive training in the complete spectrum of surgical and nonsurgical aesthetic procedures. International active members are certified by equivalent boards of their respective countries. All members worldwide adhere to a strict code of ethics and must meet stringent membership requirements.
Courtesy of The American Society for Aesthetic Plastic Surgery

Thursday, June 8, 2017

More isn't always better: making better health-care choices

More isn't always better: making better health-care choices
Canadians have more than one million unnecessary medical tests, treatments and procedures every year. But we can improve patient outcomes and save resources


By Wendy Levinson
Expert Adviser
EvidenceNetwork.ca
Wendy Levinson
Click image for Hi-Res
TORONTO, Ont./Troy Media/ - Each year, at least one million unnecessary tests, treatments and procedures are done in Canadian health-care settings. This means that hundreds of thousands of Canadians are exposed to potential harm by unnecessary care.
Unnecessary care could be a prescription drug, a diagnostic test or a medical procedure that doesn't improve a patient's health outcomes and isn't backed by the best available evidence. It may also involve risks and harmful side-effects.
In other words, this medical care offers no value to patients and strains resources.
A recent report from the Canadian Institute for Health Information (CIHI), in partnership with Choosing Wisely Canada, demonstrates how pervasive unnecessary care is across the country and highlights several key examples where changes could benefit patients and the health system.
So what are we better off without?
Unnecessary imaging has consequences.
The report says about 30 per cent of patients visiting Ontario and Alberta emergency departments for minor head injuries have CT scans. CT scans deliver strong X-ray radiation. Exposure to this radiation can increase lifetime cancer risk. Yet evidence shows there are good alternatives to CT scans for investigating head injuries. For example, doctors can use a set of questions, known as a clinical decision rule, to assess the severity of a head injury and decide if further diagnostic testing is warranted.
Unnecessary medications have side-effects.
The report estimates that one in 10 Canadian seniors regularly uses sleeping pills, known as benzodiazepines, and other sedative hypnotics. The long-term use of these medications outweighs benefits, which is why they're only recommended for short-term use. These medications increase the risk of falls causing injuries and car accidents in seniors.
Seniors aren't the only population where there is unnecessary and potentially harmful medication use. The report shows a disturbing 300 per cent increase in dispensed prescriptions for the powerful antipsychotic quetiapine for insomnia in children and youth in Manitoba, Saskatchewan and British Columbia. This drug is not recommended for children or youth and has a long list of harmful side-effects.
An important finding of the report is wide variation across regions and between provinces. Variation means major differences in medical practice, some of which are not evidence-based and can be harmful to patients.
Reducing variation improves quality for all Canadian patients and can reduce waste. A good example is pre-operative testing. In Ontario, nearly one in three patients having eye surgery had a preoperative test, compared to one in five in Alberta.
Medicine has evolved and so has medical practice. It used to be standard that before certain surgeries, like hip or knee replacements or cataract surgery, pre-operative tests would be done to ensure a patient was fit for surgery. These tests could include blood work, electrocardiograms and chest X-rays. As surgical techniques and technology evolve, however, most of these pre-operative tests are no longer needed unless there's a specific concern.
In spite of the pervasiveness of unnecessary care, the picture isn't bleak. The report also provides several examples of how health-care providers work hard to put in place better practices or protocols to reduce waste, which may also harm patients.
We know patients are aware of this problem, too. Ipsos Reid survey data shows that one in four Canadians say they have experienced unnecessary care in the past year. And 67 per cent of Canadians surveyed believe patient demand is also responsible for unnecessary care, rather than decisions made by health-care providers alone. Nearly half (42 per cent) of Canadians surveyed said they expect a test ordered or a prescription written when they visit a doctor's office.
But the vast majority (92 per cent) of Canadians surveyed also said they need more information to help make decisions and ask the right care questions.
So what should patients do?
Choosing Wisely Canada, a national, clinician-led campaign, has four key questions a patient can ask their care provider to help start a conversation about unnecessary care:
  • Do I really need this test, treatment or procedure?
  • What are the downsides?
  • Are there simpler, safer options?
  • What happens if I do nothing?
Together with health-care providers, Canadians can help reduce unnecessary care by asking questions and having conversations about when more isn't always better.
Wendy Levinson, MD, OC, is an expert adviser with EvidenceNetwork.ca, the chair of Choosing Wisely Canada and a professor of medicine at the University of Toronto.
© 2017 Distributed by Troy Media

Friday, June 2, 2017

NEAUVIA STIMULATE SAFETY: IN VITRO STRESS TEST


Injectable medical devices are products that are in direct contact with
 the patient's skin and mucosa for extended periods of time.
The complete absence of systemic and, first and foremost, direct cellular
toxicity is the essential requirement for a filler that is implanted in the skin
 and remains there for 8 months (on average).
For this reason in particular, in order to exclude even the lowest of cytotoxic
effects, increasingly sensitive cytotoxicity assays are needed - which
 means performing in vitro tests using immortalised human keratinocytes as cell line.
Cytotoxicity can be assessed with the MTT test, which relies on mitochondrial
 activity. The test, originally developed by Mosman in 1983, is simple,
ccurate and yields reproducible results (Mosman, 1983). The MTT test is
 based on the principle that, in most viable cells, mitochondrial activity is
 constant, so an increase or decrease in the number of cells is directly
 proportional to mitochondrial activity. Viable cells convert MTT tetrazolium
 salts into formazan crystals, which can be solubilised in dimethyl sulphoxide
 (DMSO) for homogeneous spectrophotometric measurement.
Therefore any change in the number of viable cells can be detected by
 measuring the optical density of formazan at 570 nm.
NEAUVIA STIMULATE Hydrogel 26 mg of HA with 1 % hydroxyapatite
 has shown complete absence of cytotoxicity at various concentrations,
 even ones higher than the normal concentration used for clinical purposes.
NEAUVIA STIMULATE is a "hybrid" filler, new, safe and reversible,
which concentrates in a single product both the tissue filling functions
of a filler and the collagen production of particle fillers, which already
 have successfully been on the market for years. The amount of collagen
produced by NEAUVIA STIMULATE is comparable to particle fillers,
 without having the problem of being irreversibile. NEAUVIA STIMULATE
 is recommended for interventions on hands, cheeks, nasoslabial
and jaw area, and the aesthetic corrections last approximately 12 months.
Prime Journal